NCT07253935

Brief Summary

The goal of this clinical trial is to evaluate whether a combined approach including therapeutic exercise, psychotherapy, and therapeutic education can improve depressive symptoms and quality of life in adults diagnosed with depression. The main questions it aims to answer are: Does a biobehavioral intervention that integrates exercise, psychotherapy, and education reduce depressive symptoms more effectively than psychotherapy alone? Does this combined approach improve quality of life, physical function, and sleep quality compared with standard psychological therapy? Researchers will compare the intervention group (therapeutic exercise + psychotherapy + education) to the control group (psychotherapy alone) to determine whether the integrated program provides greater improvements in mental health and well-being. Participants will: Complete an initial assessment including demographic data, physical tests, and validated questionnaires. Be randomly assigned to one of the two groups. If in the intervention group, take part in an 8-week telematic program consisting of graded activity, therapeutic exercise, and educational sessions. Undergo post-intervention assessments and a follow-up evaluation 12 weeks after the program ends. This study aims to provide evidence on whether combining therapeutic exercise and education with psychotherapy can enhance treatment outcomes and promote long-term adherence to physical activity in people with depression.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
12mo left

Started Dec 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Dec 2025May 2027

First Submitted

Initial submission to the registry

November 18, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 28, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

November 28, 2025

Status Verified

November 1, 2025

Enrollment Period

1.2 years

First QC Date

November 18, 2025

Last Update Submit

November 26, 2025

Conditions

Keywords

Mental disordersDepressionExercisePhysical activity

Outcome Measures

Primary Outcomes (2)

  • Depressive symptoms

    The Patient Health Questionnaire-9 (PHQ-9) will be used to assess depressive symptoms. This is a self-administered questionnaire with nine items scored on a four-point Likert scale (0-3). Higher scores indicate greater severity.

    From enrollment to the end of treatment at 8 weeks, with follow-up 12 weeks after completion of treatment.

  • Quality of life

    The World Health Organization Quality of Life Questionnaire (WHOQoL-BREF) is a self-administered instrument validated in Spanish that assesses perceived quality of life across different domains. It consists of 26 items rated on a 5-point Likert scale, yielding a total score and four domain scores: physical health, psychological health, social relationships, and environment. Scores are transformed to a 0-100 scale, with higher scores indicating better quality of life

    From enrollment to the end of treatment at 8 weeks, with follow-up 12 weeks after completion of treatment.

Secondary Outcomes (5)

  • Physical activity levels

    From enrollment to the end of treatment at 8 weeks, with follow-up 12 weeks after completion of treatment.

  • Sleep quality

    From enrollment to the end of treatment at 8 weeks, with follow-up 12 weeks after completion of treatment

  • Lower limb strength

    From enrollment to the end of treatment at 8 weeks, with follow-up 12 weeks after completion of treatment

  • Maximal oxygen uptake (V̇O2Max)

    From enrollment to the end of treatment at 8 weeks, with follow-up 12 weeks after completion of treatment

  • Self-Efficacy to Regulate Exercise

    From enrollment to the end of treatment at 8 weeks, with follow-up 12 weeks after completion of treatment

Study Arms (2)

Psychotherapy

ACTIVE COMPARATOR

Conventional psychotherapy for the treatment of depression.

Behavioral: Psychotherapy

Exercise, therapeutic education and psychotherapy

EXPERIMENTAL

Graded activity in combination with exercise, therapeutic education and psychotherapy

Behavioral: PsychotherapyBehavioral: Graded activity combined with exercise and education

Interventions

PsychotherapyBEHAVIORAL

Conventional psychotherapy for depression, including Acceptance and Commitment Therapy, Behavioral Activation, Cognitive Behavioral Therapy, Interpersonal Therapy, and Mindfulness-Based Cognitive Therapy.

Also known as: Acceptance and Commitment Therapy, Behavioral Activation, Cognitive Behavioral Therapy
Exercise, therapeutic education and psychotherapyPsychotherapy

This intervention consists of a graded activity program combined with exercise and therapeutic education in motor behavior to improve physical activity levels, self-efficacy and mood

Also known as: Biobehavioral physiotherapy, Therapeutic education, Exercise Therapy
Exercise, therapeutic education and psychotherapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of depression or dysthymia according to the ICD-11 criteria (including unspecified depressive disorder, code 6A7Z) or DSM-5-TR criteria confirmed by their referring physician.
  • A patient currently undergoing psychological treatment for depression with a score above the established cutoff in a validated depression questionnaire.

You may not qualify if:

  • Pregnancy.
  • Presence of neurological comorbidities or neurological signs.
  • Systemic rheumatic diseases, including fibromyalgia.
  • Central nervous system disorders.
  • Severe cognitive impairment.
  • Schizophrenia, psychotic disorders, or bipolar spectrum disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Diez-Quevedo C, Rangil T, Sanchez-Planell L, Kroenke K, Spitzer RL. Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients. Psychosom Med. 2001 Jul-Aug;63(4):679-86. doi: 10.1097/00006842-200107000-00021.

    PMID: 11485122BACKGROUND
  • Favela Ramírez, C. A., Castro Robles, A. I., Bojórquez Díaz, C. I., & Chan Barocio, N. L. (2022). Propiedades psicométricas del índice de calidad de sueño de Pittsburgh en deportistas. riccafd: Revista Iberoamericana de Ciencias de la Actividad Física y el Deporte, 11(3), 29-46. https://dialnet.unirioja.es/servlet/articulo?codigo=8736227

    BACKGROUND
  • Lein DH Jr, Alotaibi M, Almutairi M, Singh H. Normative Reference Values and Validity for the 30-Second Chair-Stand Test in Healthy Young Adults. Int J Sports Phys Ther. 2022 Aug 1;17(5):907-914. doi: 10.26603/001c.36432. eCollection 2022.

    PMID: 35949374BACKGROUND

MeSH Terms

Conditions

Mental DisordersDepressionMotor Activity

Interventions

PsychotherapyAcceptance and Commitment TherapyCognitive Behavioral TherapyExerciseEducational StatusExercise Therapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavioral Disciplines and ActivitiesBehavior TherapyMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaSocioeconomic FactorsPopulation CharacteristicsRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants and care providers cannot be masked due to the nature of the exercise intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2025

First Posted

November 28, 2025

Study Start

December 1, 2025

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

November 28, 2025

Record last verified: 2025-11